Oral Topotecan to Treat Recurrent or Persistent Solid Tumors
NCT00382733
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
26
Enrollment
OTHER
Sponsor class
Conditions
Tumors
Interventions
DRUG:
Oral Topotecan
Sponsor
Accelerated Community Oncology Research Network
Collaborators
[object Object]